An experienced drug development executive focused on neuromuscular disease, neuroscientist Dr. Hesterlee brings a unique background in the pharma, biotech and nonprofit sectors
Panelists will be attending live and via webcast, including live polling, to ensure a broad range of experiences and lifestyles are shared with FDA, Biopharmaceutical companies and key stakeholders